Fortress Biotech, Inc. - COM NEW (FBIO)

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / COM NEW
Number of holders
56
Total 13F shares, excl. options
4,466,852
Shares change
-493,466
Total reported value, excl. options
$16,462,217
Value change
-$434,387
Put/Call ratio
121%
Number of buys
35
Number of sells
25
Price
$3.70

Institutional Holders of Fortress Biotech, Inc. - COM NEW (FBIO) as of Q3 2025

As of 30 Sep 2025 Fortress Biotech, Inc. - COM NEW (FBIO) had 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 4,466,852 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Summit Financial, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SHIKIAR ASSET MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Sculptor Capital LP, Kestra Advisory Services, LLC, BlackRock, Inc., and HB Wealth Management, LLC.
This table shows 56 institutional shareholders of the security as of 30 Sep 2025.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.